scholarly journals Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group

eJHaem ◽  
2022 ◽  
Author(s):  
Francesca Fazio ◽  
Luca Franceschini ◽  
Valeria Tomarchio ◽  
Angela Rago ◽  
Maria Grazia Garzia ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Refractory Multiple Myeloma

Continuous low-dose dexamethasone in relapsed or refractory multiple myeloma

2000 ◽  
Vol 111 (1) ◽  
pp. 381-381 ◽  
Author(s):  
C. W. Tiplady ◽  
G. P. Summerfield
Keyword(s):  
Multiple Myeloma ◽  
Low Dose ◽  
Refractory Multiple Myeloma

Unstable Plasma Thalidomide Concentration in Patients with Refractory Multiple Myeloma

2004 ◽  
Vol 10 (3) ◽  
pp. 132-136 ◽  
Author(s):  
TOMOKO KODAMA ◽  
RYUYA HORIUCHI ◽  
NORIFUMI TSUKAMOTO ◽  
YOSHIHISA NOJIMA ◽  
HIROKAZU MURAKAMI
Keyword(s):  
Multiple Myeloma ◽  
Refractory Multiple Myeloma ◽  
Unstable Plasma
Sign in / Sign up

Export Citation Format

Share Document